Roche hires AJS CAP Solutions for Route 3 site

Pharmaceutical giant Roche has retained two real-estate development consultants to assist in the sale of the 119-acre corporate campus, straddling Clifton and Nutley, that the company is vacating.

The companies are Paulus Sokolowski and Sartor Engineering and AJS Capital Holdings LLC, both based in Warren, Roche spokesperson Darien Wilson said Tuesday.

The two consultants will "assist with development advice and the disposition process, including financial structures, infrastructure analysis, marketing data and the due diligence package for our future marketing efforts," Wilson said in an email.

"This is typically prudent and required by sellers of large real estate holdings," she said.

PS&S and AJS Capital are just advising Roche on its site, which is on Route 3 East, Wilson said, not acting as the company's real estate brokers.

"There are no plans to engage any brokers at this time," Wilson said. "The site will not be marketed until May of next year, once we have the input from the master architect and our environmental investigations are completed."

She added that the consultants' role will be complementary to the Nutley/Clifton/Roche Joint Repurposing Committee efforts. That committee in April chose New York City-based Perkins Eastman as the master plan architect for the site, which the drug maker will vacate by 2015.

Officials from PS&S and AJS Capital couldn't be reached for comment.

Founded in 1962, PS&S provides design and permitting services to corporate, institutional and commercial clients, according to its website. It is ranked among the top 15 national design firms for pharmaceuticals, according to Engineering News Record.

On its website, AJS Capital describes itself as "the management entity for a family of companies serving the private equity, banking, insurance, engineering, construction, health care, pharmaceutical, science and manufacturing industries." AJS Capital and its affiliated companies have more than 300 employees.